101 Aufrufe 101 0 Kommentare 0 Kommentare

    FINAL LFCR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Lifecore Biomedical, Inc. Investors to Join the Class Action Lawsuit!

    New York, New York--(Newsfile Corp. - September 26, 2024) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ: LFCR) and certain of its officers.

    Class Definition

    This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Lifecore securities between October 7, 2020, and March 19, 2024, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/LFCR.

    Case Details

    The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Lifecore maintained deficient internal controls over financial reporting; (2) as a result, the Company issued several financial statements that were inaccurate and would need to be restated; (3) Lifecore's purported remediation efforts with respect to the foregoing deficiencies were ineffective; (4) all of the foregoing impaired Lifecore's ability to timely file periodic reports with the SEC in compliance with NASDAQ listing requirements; (5) accordingly, the Company's financial position and/or prospects were materially overstated; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

    What's Next?

    A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/LFCR or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Lifecore you have until September 27, 2024, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

    There is No Cost to You

    We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

    Why Bronstein, Gewirtz & Grossman

    Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

    Attorney advertising. Prior results do not guarantee similar outcomes.

    Contact

    Bronstein, Gewirtz & Grossman, LLC
    Peretz Bronstein or Nathan Miller
    332-239-2660 | info@bgandg.com

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218438


    The Lifecore Biomedical Stock at the time of publication of the news with a fall of -0,70 % to 4,23USD on Lang & Schwarz stock exchange (26. September 2024, 22:00 Uhr).


    newsfile
    0 Follower
    Autor folgen

    Verfasst von newsfile
    FINAL LFCR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Lifecore Biomedical, Inc. Investors to Join the Class Action Lawsuit! New York, New York--(Newsfile Corp. - September 26, 2024) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore Biomedical, Inc. ("Lifecore" or "the …